Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Dubsky

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
The Breast Journal|January 29, 2013
Impact of HER-2-targeted therapy on overall survival in patients with HER-2 positive metastatic breast cancerAnna S Berghoff, Zsuzsanna Bago-Horvath, Peter Dubsky, et al.
JAMA Oncology|February 17, 2018
Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialIvana Sestak, Richard Buus, Jack Cuzick, et al.
Eclinicalmedicine|January 25, 2021
What we learned in axillary management of breast cancer patients at the American society of clinical oncology (ASCO) 2020 virtual meeting? The EUBREAST point of viewMaria Luisa Gasparri, Philip Poortmans, Maggie Banys-Paluchowski, et al.
Clinical Breast Cancer|June 30, 2009
Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?Michael Gnant, Peter Dubsky, Florian Fitzal, et al.
Investigative Radiology|February 26, 2014
Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imagingKatja Pinker, Wolfgang Bogner, Pascal Baltzer, et al.
Cancer Medicine|July 27, 2016
Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapyRuth Exner, Monika Sachet, Tobias Arnold, et al.
Breast Cancer Research and Treatment|April 10, 2007
Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patientsFlorian Fitzal, Otto Riedl, Lisa Wutzl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2020
Prognostic Value of EndoPredict in Women with Hormone Receptor-Positive, HER2-Negative Invasive Lobular Breast CancerIvana Sestak, Martin Filipits, Richard Buus, et al.
Radiology|March 10, 2015
Multiparametric MR Imaging with High-Resolution Dynamic Contrast-enhanced and Diffusion-weighted Imaging at 7 T Improves the Assessment of Breast Tumors: A Feasibility StudyKatja Pinker, Pascal Baltzer, Wolfgang Bogner, et al.
Cancer|December 12, 2003
Do we need HER-2/neu testing for all patients with primary breast carcinoma?Susanne Taucher, Margaretha Rudas, Robert M Mader, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
The Breast Journal|January 29, 2013
Impact of HER-2-targeted therapy on overall survival in patients with HER-2 positive metastatic breast cancerAnna S Berghoff, Zsuzsanna Bago-Horvath, Peter Dubsky, et al.
JAMA Oncology|February 17, 2018
Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialIvana Sestak, Richard Buus, Jack Cuzick, et al.
Eclinicalmedicine|January 25, 2021
What we learned in axillary management of breast cancer patients at the American society of clinical oncology (ASCO) 2020 virtual meeting? The EUBREAST point of viewMaria Luisa Gasparri, Philip Poortmans, Maggie Banys-Paluchowski, et al.
Clinical Breast Cancer|June 30, 2009
Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?Michael Gnant, Peter Dubsky, Florian Fitzal, et al.
Investigative Radiology|February 26, 2014
Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imagingKatja Pinker, Wolfgang Bogner, Pascal Baltzer, et al.
Cancer Medicine|July 27, 2016
Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapyRuth Exner, Monika Sachet, Tobias Arnold, et al.
Breast Cancer Research and Treatment|April 10, 2007
Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patientsFlorian Fitzal, Otto Riedl, Lisa Wutzl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2020
Prognostic Value of EndoPredict in Women with Hormone Receptor-Positive, HER2-Negative Invasive Lobular Breast CancerIvana Sestak, Martin Filipits, Richard Buus, et al.
Radiology|March 10, 2015
Multiparametric MR Imaging with High-Resolution Dynamic Contrast-enhanced and Diffusion-weighted Imaging at 7 T Improves the Assessment of Breast Tumors: A Feasibility StudyKatja Pinker, Pascal Baltzer, Wolfgang Bogner, et al.
Cancer|December 12, 2003
Do we need HER-2/neu testing for all patients with primary breast carcinoma?Susanne Taucher, Margaretha Rudas, Robert M Mader, et al.
Pageof 10